Shari L. Allen
Plus aucun poste en cours
Profil
Shari L.
Allen worked as Vice President-Clinical & Regulatory Affairs at Aptus Endosystems, Inc. and as Principal at W.
L.
Gore & Associates, Inc. She also worked as Head-Clinical & Regulatory Affairs at Bard Peripheral Vascular Technologies.
In 2010-2011, she served as Vice President-Clinical, Regulatory & Quality at Trivascular2, Inc. Ms. Allen completed her undergraduate degree from the University of Virginia.
Anciens postes connus de Shari L. Allen
| Sociétés | Poste | Fin |
|---|---|---|
Trivascular2, Inc.
 Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Directeur Technique/Scientifique/R&D | 02/12/2011 |
| Bard Peripheral Vascular Technologies | Corporate Officer/Principal | - |
W. L. Gore & Associates, Inc.
 W. L. Gore & Associates, Inc. Chemicals: SpecialtyProcess Industries W. L. Gore & Associates, Inc. develops and manufactures products derived from fluoropolymers. It offers consumer products, cable and cable assemblies, electronic and electrochemical material, fabrics, fibers, filtration, medical, pharmaceutical processing, sealants and venting. The company was founded by Wilbert Lee Gore and Genevieve W. Gore on January 1, 1958 and is headquartered in Newark, DE. | Corporate Officer/Principal | - |
Aptus Endosystems, Inc.
 Aptus Endosystems, Inc. Medical SpecialtiesHealth Technology Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Shari L. Allen
| University of Virginia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Aptus Endosystems, Inc.
Aptus Endosystems, Inc. Medical SpecialtiesHealth Technology Aptus Endosystems, Inc. develops and manufactures medical equipment. It focuses on developing technologies to transform Endovascular Aneurysm Repair (EVAR), empowering physicians to perform minimally invasive aneurysm repair while still providing the control and potential long term durability of open surgical repair. The company was founded by Alan Kaganov and Lee Bolduc on August 7, 2002 and is headquartered in Sunnyvale, CA. | Health Technology |
| Bard Peripheral Vascular Technologies | |
W. L. Gore & Associates, Inc.
W. L. Gore & Associates, Inc. Chemicals: SpecialtyProcess Industries W. L. Gore & Associates, Inc. develops and manufactures products derived from fluoropolymers. It offers consumer products, cable and cable assemblies, electronic and electrochemical material, fabrics, fibers, filtration, medical, pharmaceutical processing, sealants and venting. The company was founded by Wilbert Lee Gore and Genevieve W. Gore on January 1, 1958 and is headquartered in Newark, DE. | Process Industries |
Trivascular2, Inc.
Trivascular2, Inc. Medical SpecialtiesHealth Technology Trivascular2, Inc. has pioneered numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular's initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, its products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare. | Health Technology |
